跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-TERIPARATIDE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-TERIPARATIDE INJECTION
Authorized
STANDARD
TEVA-TERIPARATIDE INJECTION
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
11624583cabf5d10
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
11624583cabf5d10
Drug Approval Canada Name
TEVA-TERIPARATIDE INJECTION
Product Name
TEVA-TERIPARATIDE INJECTION
Status
Marketed
Status Date
2020-07-08
Original Market Date
2020-07-08
Din
02486423
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
68:24.08
Atc Original
H05AA02 TERIPARATIDE
Atc Name
h 05 aa 02
Aig Number
0150152001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
TERIPARATIDE (TERIPARATIDE ACETATE)
250 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
11624583cabf5d10
Type
Standard
Back to Health Canada Approvals